Medication info
Bonvis Tablet 150 mg (Ibandronate Sodium Hydrate)

Bonvis Tablet 150 mg (Ibandronate Sodium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Ibandronate Sodium Monohydrate›168.75mg / 1 tablet
Manufacturer / importer
PharmGen Science Co., Ltd.
Appearance
White to almost white oblong film-coated tablet
Packaging
1 tablet/PTP, 10 tablets/PTP (1 tablet/PTP package × 10 EA)
Approval status
Active

MFDS item code 201306202 · Approved 2013.03.14 · Insurance code 670103390

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Take 1 tablet once a month, regularly on the same day each month in the morning, with a sufficient amount of water, at least 1 hour before consuming food, beverages (other than water), other oral medicines, or dietary supplements (including calcium): - Swallow this medicine with a sufficient amount (180-240ml) of water while standing or sitting upright, and do not lie down for 60 minutes after taking it. - Take it with plain water, as mineral water may reduce absorption of this medicine. - Do not chew or suck the tablet, to avoid esophageal ulcers. If the patient forgets to take a dose on the regularly scheduled day: - If 8 days or more remain until the next scheduled dose, take 1 tablet the morning after realizing that the dose was missed, and thereafter take 1 tablet each month on the originally scheduled day. - If 7 days or fewer remain until the next scheduled dose, take 1 tablet on the next scheduled day, and thereafter continue taking 1 tablet each month on the originally scheduled day. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is necessary. Patients with renal impairment No dose adjustment is necessary in patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or higher. As clinical experience is insufficient in patients with creatinine clearance below 30mL/min, use of this medicine is not recommended. Elderly patients No dose adjustment is necessary.
Child dose
The efficacy and safety of this medicine have not been studied in children under 18 years of age.

Ingredients

Manufacturer
PharmGen Science Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medicine is used for the treatment of osteoporosis, which mainly occurs in postmenopausal women. The decrease in female hormones due to menopause reduces bone density, increasing the risk of fractures. This medication helps maintain bone health and increases bone density, thus preventing fractures. Therefore, it is used to effectively manage postmenopausal osteoporosis and keep bones strong.

How to take

Adult dose

Take 1 tablet once a month, regularly on the same day each month in the morning, with a sufficient amount of water, at least 1 hour before consuming food, beverages (other than water), other oral medicines, or dietary supplements (including calcium): - Swallow this medicine with a sufficient amount (180-240ml) of water while standing or sitting upright, and do not lie down for 60 minutes after taking it. - Take it with plain water, as mineral water may reduce absorption of this medicine. - Do not chew or suck the tablet, to avoid esophageal ulcers. If the patient forgets to take a dose on the regularly scheduled day: - If 8 days or more remain until the next scheduled dose, take 1 tablet the morning after realizing that the dose was missed, and thereafter take 1 tablet each month on the originally scheduled day. - If 7 days or fewer remain until the next scheduled dose, take 1 tablet on the next scheduled day, and thereafter continue taking 1 tablet each month on the originally scheduled day. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is necessary. Patients with renal impairment No dose adjustment is necessary in patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or higher. As clinical experience is insufficient in patients with creatinine clearance below 30mL/min, use of this medicine is not recommended. Elderly patients No dose adjustment is necessary.

Child dose

The efficacy and safety of this medicine have not been studied in children under 18 years of age.

Precautions

This medicine should not be used in patients who are allergic to this medicine or any other components of this medicine. Patients with low calcium levels should normalize calcium levels before taking this medication. After taking the medication, patients must remain upright for at least 60 minutes and should not lie down while taking it. Patients with slow or problematic esophageal movement should be cautious as this medication may irritate or damage the esophagus. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Patients with severely impaired kidney function, especially those with a creatinine clearance of less than 30 mL/min, should use this medicine carefully. Gastrointestinal disturbances may occur upon taking this medication; if symptoms such as heartburn, difficulty swallowing, or chest pain occur, immediately consult a doctor. This medication can irritate the gastrointestinal mucosa; therefore, patients with gastritis, esophagitis, ulcers, etc., should be especially cautious. Patients undergoing dental treatment or with poor oral health should have a dental check-up before using this medicine and receive preventive treatments if necessary. It is advisable to avoid excessive dental treatments or surgeries during the use of this medication, and to inform medical staff immediately if any symptoms of jawbone abnormalities occur. This medication can cause eye inflammation, so patients should inform their doctor immediately if any eye symptoms occur. Pain such as myalgia, arthralgia, or bone pain may occur, and if these symptoms are severe, consult a doctor. This medication may have reduced absorption if taken with calcium, milk, antacids, etc., so avoid taking other foods or medications for at least one hour after taking it. It is safer not to use this medicine during pregnancy or breastfeeding. The safety and efficacy of this medicine have not been established in children under 18 years of age, therefore it should not be used in this age group. Overdose may lead to gastrointestinal disturbances or hypocalcemia; therefore, strictly adhere to the dosage and inform medical staff immediately if any symptoms occur. This medication should be stored out of the reach of children, and unused medicine should be safely disposed of using designated methods to prevent environmental pollution.

Side effects

dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, stricture, dizziness, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial swelling, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, allergic reaction, Stevens-Johnson syndrome, erythema multiforme, bullous dermatitis, atypical femoral fracture, subtrochanteric femoral fracture, abnormal sensation in the eyes, asthenia, pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees. This helps maintain the effectiveness of the medicine.

Appearance and packaging

Appearance

White to almost white oblong film-coated tablet

Package unit

1 tablet/PTP, 10 tablets/PTP (1 tablet/PTP package × 10 EA)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.